Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | TCM_Taiwan* | |||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | urine | Merck Manual of Diagnosis and Therapy. | ||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | DOI[10.1038/nbt.2488] | |||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | saliva |
PMID[22308371] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | blood |
PMID[7296840] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | breast milk |
PMID[24027187] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | cerebrospinal fluid |
PMID[18502700] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | amniotic fluid |
PMID[16139832] |
||
NPO20338 | Mus musculus | Species | Muridae | Eukaryota |
PMID[17190852] |
|||
NPO29132 | Agaricus campestris | Species | Agaricaceae | Eukaryota | TCM_Taiwan* | |||
NPO6884 | Ailanthi cortex | NA | NA | NA | TCMSP* | |||
NPO29132 | Agaricus campestris | Species | Agaricaceae | Eukaryota | TCMID* | |||
NPO11969 | Cyprinus carpio | Species | Cyprinidae | Eukaryota | TCMID* | |||
NPO12323 | Bos taurus | Species | Bovidae | Eukaryota | TCMID* | |||
NPO17393 | Bubalus bubalis | Species | Bovidae | Eukaryota | TCMID* | |||
NPO5178 | Pelophylax nigromaculatus | Species | Ranidae | Eukaryota | TCMID* | |||
NPO913 | Pelophylax plancyi | Species | Ranidae | Eukaryota | TCMID* | |||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT613 | Individual Protein | Solute carrier family 22 member 1 | Homo sapiens | Inhibition | = | 13.3 | % | 18788725 |
NPT1414 | Organism | Drosophila | Drosophila | Activity | = | 58 | % | 18327252 |
NPT1414 | Organism | Drosophila | Drosophila | Activity | = | 123.2 | % | 18327252 |
NPT1414 | Organism | Drosophila | Drosophila | Activity | = | 69 | % | 18327252 |
NPT1038 | Individual Protein | Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 3696.4 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 100000 | nM | PubChem BioAssay data set | |
NPT1006 | Individual Protein | Proton-coupled amino acid transporter 1 | Homo sapiens | Ki | = | 15000000 | nM | 21955456 |
NPT2 | Others | Unspecified | Potency | 161.4 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 1584.9 | nM | PubChem BioAssay data set | |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 105.71 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 93.64 | % | 23571415 |
NPT446 | Individual Protein | Rap guanine nucleotide exchange factor 3 | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 118.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 29849.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 5011.9 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC27836 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.8 | Intermediate Similarity | NPC141953 |
0.8 | Intermediate Similarity | NPC153556 |
0.6875 | Remote Similarity | NPC195448 |
0.6122 | Remote Similarity | NPC40511 |
0.5769 | Remote Similarity | NPC314598 |
0.5769 | Remote Similarity | NPC182969 |
0.5682 | Remote Similarity | NPC328698 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC27836 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD8607 | Phase 3 |
0.8 | Intermediate Similarity | NPD8587 | Approved |
0.6875 | Remote Similarity | NPD8621 | Approved |
0.66 | Remote Similarity | NPD8583 | Phase 2 |
0.6346 | Remote Similarity | NPD8574 | Phase 2 |
0.6341 | Remote Similarity | NPD8613 | Approved |
0.6226 | Remote Similarity | NPD8815 | Suspended |
0.6 | Remote Similarity | NPD8545 | Approved |
0.5789 | Remote Similarity | NPD8864 | Clinical (unspecified phase) |
PubChem CID   | 588 |
ChEMBL   | CHEMBL65567 |
ZINC   |
Molecular Weight:   | 113.06 |
ALogP:   | -0.7855 |
MLogP:   | 1.46 |
XLogP:   | 0.015 |
# Rotatable Bonds:   | 2 |
Polar Surface Area:   | 59.68 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 2 |
# Rings:   | 1 |
# Heavy Atoms:   | 8 |